Herpes Zoster clinical trials

Explore recruiting herpes zoster clinical trials.

Recruiting herpes zoster studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Herpes Zoster trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Herpes zoster after recombinant herpes zoster vaccination - Immediate post-RHZ-vaccination evolution of CMI, HMI and lymphocyte count and typing.

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Prospective Randomized trial of Everolimus replacing MMF/MP Acid by the RECOVAC consortium to increase VACcine response in kidney transplant patients

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

A Pragmatic Randomized Trial to Evaluate the Effect of Recombinant Herpes Zoster Vaccine on Major Adverse Cardiovascular Events and Dementia in Adults Aged 65 Years or Above

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A phase 3b, open-label, multi-country, multi-centre, long-term follow-up study of ZOSTER-049 (follow- up of ZOSTER-006/022 studies) to assess the prophylactic efficacy, safety and persistence of immune response of a Herpes Zoster subunit vaccine and assessment of persistence of immune response and safety of 1 or 2 additional doses administered in ZOSTER-049 in 2 subgroups of older adults.

Sweden, Finland, Estonia, France, Spain, Czechia +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Efficacyand Safety Study Of Daxdilimab Subcutaneous Injection In Adult Participants With Inadequately Controlled Dermatomyositis Or Anti-Synthetase Inflammatory Myositis

Spain, Italy, Germany, Czechia, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized Trial of the I-BFM-SG for the Management of Childhood non-mature-B Acute Lymphoblastic Leukemia

Greece, Hungary, Croatia, Slovenia

Therapeutic use (Phase IV) EU CTIS Study details

Herpes Zoster trials by city

Herpes Zoster in Toronto Herpes Zoster in Vancouver Herpes Zoster in Montreal Herpes Zoster in Calgary Herpes Zoster in Edmonton Herpes Zoster in Ottawa Herpes Zoster in Winnipeg Herpes Zoster in Quebec City Herpes Zoster in Hamilton Herpes Zoster in Kitchener Herpes Zoster in London Herpes Zoster in Halifax Herpes Zoster in New York Herpes Zoster in Los Angeles Herpes Zoster in Chicago Herpes Zoster in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease